The silent threat: investigating the incidence and clinical characteristics of pre-eclampsia and eclampsia in women from tertiary care hospitals of the Democratic Republic of Congo
Olivier Nyakio(Faculty (United Kingdom)), Aymar Akilimali(Roslin Institute), Tarun Kumar Suvvari(Andhra University), Louison Kena(Université libre des Pays des Grands Lacs), Hugues Cakwira(Green Circle), Nathan Mugenyi(Mbarara University of Science and Technology), Malik Olatunde Oduoye(Ahmadu Bello University), Gaston Masimango(Green Circle), Toussaint Amani(Université libre des Pays des Grands Lacs), Farheen Naaz(Deccan College of Medical Sciences), Vérité K. Cyubahiro(University of Kigali), Gaurang Narayan(Indira Gandhi Government Medical College & Hospital)
Cited by 1
Related Papers
Revolutionary breakthrough: FDA approves CASGEVY, the first CRISPR/Cas9 gene therapy for sickle cell disease
|Annals of Medicine and Surgery|2024|87
Impacts of the advancement in artificial intelligence on laboratory medicine in low‐ and middle‐income countries: Challenges and recommendations—A literature review
|Health Science Reports|2024|62
Revolutionary breakthrough: FDA approves Vyjuvek, the first topical gene therapy for dystrophic epidermolysis bullosa
|Annals of Medicine and Surgery|2023|30
Self-medication and Anti-malarial Drug Resistance in the Democratic Republic of the Congo (DRC): A silent threat
|Tropical Medicine and Health|2022|29